Clinical study of autologous bone marrow stem cell transplantation in the treatment of decompensated cirrhosis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037421

Enrollment

Unknown

Registered

2020-08-28

Start date

2020-10-16

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decompensated cirrhosis

Interventions

BM-MSC:Portal vein reinfusion

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with severe chronic hepatitis; 2. Patients with intermediate or advanced cirrhosis, including alcoholic cirrhosis, hepatitis cirrhosis, immune cirrhosis, drug-induced cirrhosis, and biliary cirrhosis; 3. Early and middle stage of severe liver disease; 4. Aged 20-65 years.

Exclusion criteria

Exclusion criteria: 1. Cirrhosis associated with severe coagulation dysfunction, severe gastrointestinal bleeding, and severe hepatic coma; 2. Definite history of liver cancer; 3. Severe heart, liver, kidney and lung failure; 4. Patients with poor general conditions who cannot tolerate stem cell transplantation surgery; 5. Severe systemic infection not under control; 6. Contrast allergy.

Design outcomes

Primary

Measure	Time frame
liver function;	—

Countries

China

Contacts

Public ContactFeng Yu

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

davisfy@126.com+86 13918836488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026